Zura Bio Appoints New CEO, CFO, and Directors

Ticker: ZURA · Form: 8-K · Filed: Oct 18, 2024 · CIK: 1855644

Zura Bio Ltd 8-K Filing Summary
FieldDetail
CompanyZura Bio Ltd (ZURA)
Form Type8-K
Filed DateOct 18, 2024
Risk Levelmedium
Pages1
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: leadership-change, management-appointment

TL;DR

Zura Bio just swapped out its CEO and CFO, bringing in new blood to lead the charge.

AI Summary

Zura Bio Ltd. announced on October 15, 2024, a significant change in its leadership structure. The company elected three new directors: Dr. Jonathan Lim, Dr. David Sidransky, and Mr. David E. Johnson. Concurrently, the company appointed Dr. Lim as the new Chief Executive Officer and Chairman of the Board, and Mr. Johnson as the Chief Financial Officer. These appointments are effective immediately.

Why It Matters

The appointment of a new CEO and CFO, along with new board members, often signals a strategic shift or a new phase of growth for the company.

Risk Assessment

Risk Level: medium — Leadership changes can introduce uncertainty regarding future strategy and execution, impacting investor confidence.

Key Players & Entities

  • Zura Bio Ltd (company) — Registrant
  • Dr. Jonathan Lim (person) — Newly appointed CEO and Chairman of the Board
  • Dr. David Sidransky (person) — Newly elected Director
  • Mr. David E. Johnson (person) — Newly appointed CFO
  • October 15, 2024 (date) — Date of earliest event reported

FAQ

Who are the newly elected directors of Zura Bio Ltd?

The newly elected directors are Dr. Jonathan Lim, Dr. David Sidransky, and Mr. David E. Johnson.

What is the effective date of these appointments?

The appointments are effective as of October 15, 2024.

What positions have been filled by Dr. Jonathan Lim?

Dr. Jonathan Lim has been appointed as the Chief Executive Officer and Chairman of the Board.

Who has been appointed as the new Chief Financial Officer?

Mr. David E. Johnson has been appointed as the new Chief Financial Officer.

What is the principal executive office address for Zura Bio Ltd?

The address of the principal executive offices is 1489 W. Warm Springs Rd. #110 Henderson, NV 89014.

Filing Stats: 425 words · 2 min read · ~1 pages · Grade level 12 · Accepted 2024-10-18 16:15:23

Key Financial Figures

  • $0.0001 — ed Class A Ordinary Shares, par value $0.0001 per share ZURA The Nasdaq Stock Mar

Filing Documents

02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On and effective October 15, 2024, Michael Howell, the Chief Scientific Officer of Zura Bio Limited (the " Company "), was separated from the Company. Dr. Howell's separation was not related to the Company's financial or operating results or to any disagreements regarding the Company's operations or financial or reporting practices.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 18, 2024 ZURA BIO LIMITED By: /s/ Kim Davis Kim Davis Chief Legal Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.